Rubius Therapeutics, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q1 2018 to Q1 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Rubius Therapeutics, Inc. annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q1 2018 to Q1 2022.
- Rubius Therapeutics, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2022 was $1.43M, a 35.2% increase year-over-year.
- Rubius Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $4.39M, a 13.8% decline from 2021.
- Rubius Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $5.09M, a 33.2% increase from 2020.
- Rubius Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $3.82M, a 29.1% increase from 2019.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)